NEW YORK (GenomeWeb News) – Illumina has named Joel McComb senior VP and GM of Life Sciences, and Gregory Heath as senior VP and GM of the company’s Diagnostics Business unit.
 
McComb was president of Interventional Medicine at GE Healthcare, and he formerly was president and CEO of Innovadyne Technologies. He also was GM of Primary Care Diagnostics and director of corporate business development at Beckman Coulter.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.